首页 | 本学科首页   官方微博 | 高级检索  
检索        

3q27-3q29相关的p63蛋白表达在弥漫性大B细胞淋巴瘤中的意义
引用本文:陈振文,王晋芬,王国平,张宏伟,刘冬梅,徐义荣,张朝霞,田林.3q27-3q29相关的p63蛋白表达在弥漫性大B细胞淋巴瘤中的意义[J].白血病.淋巴瘤,2010,19(3):161-165.
作者姓名:陈振文  王晋芬  王国平  张宏伟  刘冬梅  徐义荣  张朝霞  田林
作者单位:山西医科大学汾阳学院病理学教研室,032200;山西省肿瘤医院病理科;华中科技大学同济医学院病理学系;山西省肿瘤医院血液科;山西医科大学附属汾阳医院病理科
摘    要: 目的 探讨3q27-3q29相关的p63蛋白表达在弥漫性大B细胞淋巴瘤(DLBCL)中的意义。方法 应用免疫组织化学EnVision二步法检测102例DLBCL与15例反应性淋巴组织增生(RHL)中p53蛋白和3q27-3q29相关的p63蛋白的表达并进行随访。结果 p53、p63蛋白在DLBCL中的阳性率分别为62 %和56 %,在RHL中的阳性率分别为0和13 %,p53、p63蛋白在DLBCL与RHL中比较差异均有统计学意义(P<0.05);p53、p63蛋白的表达在Ⅰ+Ⅱ期中的阳性率分别为48.3 %和41.4 %,在Ⅲ+Ⅳ期中的阳性率分别为79.5 %和75 %,差异有统计学意义(P<0.05);p53、p63蛋白的表达在生发中心B细胞型(GCB型)中的阳性率分别为28 %和28 %,在非GCB型(non-GCB型)中的阳性率分别为72.7 %和64.9 %,差异均有统计学意义(P<0.05)。p53、p63蛋白表达与患者性别、年龄、有无B症状和发病部位等无相关性(P>0.05)。p53蛋白表达与p63蛋白表达呈正相关性(r=0.629,P<0.05)。p53、p63蛋白表达阴性组的5年总体生存率高于阳性组(38 %∶6 %,51 %∶4 %),差异有统计学意义(P<0.05)。结论 p63可能作为癌基因与p53共同参与了DLBCL的发生和发展,两者在肿瘤的发生中可能起着协同作用;联合检测p63蛋白和p53蛋白在DLBCL中的表达,可能成为判断DLBCL预后指标之一。

关 键 词:淋巴瘤  大细胞  弥漫型  基因  p53  p63  3q27-3q29  免疫组织化学3.山西省肿瘤医院血液科
收稿时间:2010-01-13;

Significance of 3q27-3q29-related p63 protein expression in diffuse large B-cell lymphoma
CHEN Zhen-wen,WANG Jin-fen,WANG Guo-ping,ZHANG Hong-wei,LIU Dong-mei,XU Yi-rong,ZHANG Zhao-xia,TIAN Lin.Significance of 3q27-3q29-related p63 protein expression in diffuse large B-cell lymphoma[J].Journal of Leukemia & Lymphoma,2010,19(3):161-165.
Authors:CHEN Zhen-wen  WANG Jin-fen  WANG Guo-ping  ZHANG Hong-wei  LIU Dong-mei  XU Yi-rong  ZHANG Zhao-xia  TIAN Lin
Institution:. (Department of Pathology, Fenyang College of Shanxi Medical University, Fenyang 032200, China)
Abstract:Objective To investigate the expressions and clinicopathological significance of 3q27-3q29-related p63 protein in diffuse large B-cell lymphoma (DLBCL). Methods An immunohistochemical Envision~(TM) method was used to detect the expressions of p53 and 3q27-3q29-related p63 protein in 102 cases of DLBCL and 15 cases of reactive hyperplasia of lymph node (RHL). Results The tumor cell expressions of p53(62 %) and p63(56 %) in DLBCL were significantly higher than that in RHL (0 and 13 % P < 0.05). The expressions of p53 and p63 were significantly different (1) between stage Ⅰ + Ⅱ (the positive rate 48.3 % and 41.4 %, respectively) and stage Ⅲ+Ⅳ(the positive rate 79.5 % and 75 %, respectively; P <0.05), (2) between GCB type (the positive rate 28 % and 28 %, respectively) and non-GCB type(the positive rate 72.7 % and 64.9 %, respectively; P <0.05). The expressions of p53 and p63 had no relationship to gender, age, B symptoms and locations. The expression of p53 was positively correlated with that of p63 in DLBCL (P <0.05, Cp=0.629). p53 and p63 protein expression in negative group the 5-year overall survival rate is higher than that in positive group (38 % and 6 %, 51% and 4 %, respectively), the difference was statistically significant (P <0.05). Conclusion It was likely that p63, as the oncogene, participated in the occurrence and development of DLBCL together with p53. Also, p63 and p53 might play a synergistic role in the occurrence DLBCL. Combined detection of 3q27-3q29-related 1963 protein and p53 protein in DLBCL, might be one of the indicators to the prognosis of DLBCL.
Keywords:p53  p63  3q27-3q29
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《白血病.淋巴瘤》浏览原始摘要信息
点击此处可从《白血病.淋巴瘤》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号